Novo Nordisk A/S is rebranding an existing, less-popular diabetes tablet as Ozempic in the US in a bid to capitalize on the ...

Novo Nordisk (NVO) announced on Friday that the company will launch its oral GLP-1 receptor agonist semaglutide under the ...

Novo Nordisk, which makes the GLP-1 semaglutide medications Ozempic and Wegovy, announced that it’s rolling out an “Ozempic ...

Novo Nordisk announced that starting Monday, May 4, Ozempic® (semaglutide) tablets 1.5 mg, 4 mg, and 9 mg will be available ...

The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral semaglutide version.

Novo Nordisk is giving one of its biggest drugs a new twist, rolling out an Ozempic pill in the U.S. starting next week. The company says ...

Novo Nordisk said April 23 it plans to seek expanded FDA approval for its Ozempic pill in the second half of 2026, which would make the drug the first oral GLP-1 approved for children and adolescents ...

Novo Nordisk (NYSE:NVO) is advancing the launch of an oral version of Ozempic, expanding its GLP-1 diabetes franchise beyond injectable formats. The company is also seeking regulatory approvals to ...

GoodRx and Weight Watchers both separately announced on Friday that they will start offering weight-loss pills. GoodRx, which gives users access to coupons on pharmaceuticals, said it is expanding ...

WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it will begin offering access to Novo Nordisk’s now available Ozempic ® ...

The Canadian health regulator has approved Apotex's generic version of semaglutide, marking it as the second authorized ...

Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.